AzTrials
AzTrials

Sacroiliac Joint PainSI-DENNCT07486674

Endoscopic and Cryoablation Denervation for Sacroiliac Joint Pain

A study testing Cryoablation and Endoscopic Denervation in people with Sacroiliac Joint Pain and Chronic Pain, run by EPC Education s.r.o. at 1 site in Slovakia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This interventional study compares cryoablation and endoscopic denervation for the treatment of posterior sacroiliac joint pain in patients with chronic sacroiliac joint pain confirmed by a positive diagnostic block. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Sacroiliac Joint Pain, Chronic Pain
What is being tested?
Cryoablation and Endoscopic Denervation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
51 participants
Where
1 siteSlovakia
Study dates
20 Apr 2023to 15 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adults aged 18 years or older
  • chronic sacroiliac joint pain
  • positive sacroiliac joint provocation maneuvers
  • positive diagnostic block of the dorsal branches of L5 and S1-S3 under fluoroscopic guidance
  • at least 70% pain relief after diagnostic block
  • ability to understand the study procedures and provide written informed consent

Who cannot join

  • radicular pain caused by lumbar disc herniation or other dominant spinal pathology
  • spinal tumor, infection, fracture, or inflammatory spinal disease
  • coagulation disorder or ongoing anticoagulant therapy contraindicating the procedure
  • pregnancy
  • severe psychiatric or medical condition preventing reliable follow-up
  • refusal to participate in the study

Trial locations and contacts

1 site in 1 country.

Slovakia1 site
  • EuroPainClinics Košice

    Košice, Košice Region, 04011

Other trials in Slovakia

About this study

Official title: Prospective Study Evaluating Cryoablation and Endoscopic Denervation of the Dorsal Sacroiliac Joint Innervation (Ramus Dorsalis L5 and S1-S3) in Patients With Sacroiliac Joint Pain

This interventional study compares cryoablation and endoscopic denervation for the treatment of posterior sacroiliac joint pain in patients with chronic sacroiliac joint pain confirmed by a positive diagnostic block. The aim is to evaluate and compare the effectiveness of both procedures in reducing pain and improving functional status.

Read the detailed description

Posterior sacroiliac joint pain is a common cause of chronic low back pain and may substantially impair daily functioning and quality of life. In patients with a positive diagnostic block confirming the sacroiliac joint as the source of pain, interventional procedures targeting the dorsal branches of L5 and S1-S3 may provide pain relief.

This study compares two interventional treatment methods: cryoablation and endoscopic denervation. Patients with confirmed posterior sacroiliac joint pain undergo one of these procedures after diagnostic confirmation of the pain source. Cryoablation is performed on the dorsal branches of L5 and S1-S3. Endoscopic denervation is performed on the same target nerves using an endoscopic approach.

The study evaluates the comparative effectiveness of these procedures in terms of pain reduction and functional improvement over follow-up. The findings may help clarify the role of these two techniques in the management of chronic posterior sacroiliac joint pain.

Being tested
Cryoablation, Endoscopic Denervation
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CryoablationProcedure or surgery

    Percutaneous cryoablation of the dorsal branches of L5 and S1-S3 under imaging guidance for treatment of posterior sacroiliac joint pain after a positive diagnostic block.

  • Endoscopic DenervationProcedure or surgery

    Endoscopic denervation of the dorsal branches of L5 and S1-S3 for treatment of posterior sacroiliac joint pain after a positive diagnostic block.

Study groups in NCT07486674
Study groupRoleWhat they receive
CryoablationExperimentalPatients with sacroiliac joint pain underwent cryoablation of the dorsal branches of L5 and S1-S3 after a positive diagnostic block confirming posterior sacroiliac joint pain.
Receives: Procedure: Cryoablation
Endoscopic DenervationExperimentalPatients with sacroiliac joint pain underwent endoscopic denervation of the dorsal branches of L5 and S1-S3 after a positive diagnostic block confirming posterior sacroiliac joint pain.
Receives: Procedure: Endoscopic Denervation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity measured by Numeric Rating Scale (NRS)

    Change in pain intensity measured using an 11-point Numeric Rating Scale (0 = no pain, 10 = worst imaginable pain).

    Measured: Baseline and 12 months follow-up

  2. Functional disability measured by Oswestry Disability Index (ODI)

    Change in functional disability assessed using the Oswestry Disability Index (0-100%, higher scores indicate greater disability).

    Measured: Baseline and 12 months follow-up

Secondary outcomes (3)
  1. Change From Baseline EuroQol-5 Dimension (EQ-5D-5L) at 12 Months

    Change in health-related quality of life assessed using the EQ-5D-5L questionnaire, including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.

    Measured: Baseline and 12 months follow-up

  2. Procedure-Related Complications

    Occurrence and type of adverse events or complications related to cryoablation or endoscopic denervation.

    Measured: From procedure up to 24 months follow-up

  3. Analgesic consumption measured as daily dose (mg/day)

    Change in analgesic medication use expressed as daily dose in milligrams per day.

    Measured: Baseline and 12 months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2026
  2. Study start20 Apr 2023
  3. Primary completion20 Apr 2025
  4. Study completion15 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Patients with sacroiliac joint pain and a positive diagnostic block of the dorsal branches of L5 and S1-S3 were assigned to one of two treatment groups according to the performed intervention: cryoablation or endoscopic denervation.
Masking
None (open label)
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07486674
Sponsor's protocol ID
SI-DEN-2019
Acronym
SI-DEN
Status last verified
Mar 2026
First submitted
15 Mar 2026
Last updated
20 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Cryoablation and Endoscopic Denervation in people with Sacroiliac Joint Pain and Chronic Pain, run by EPC Education s.r.o. at 1 site in Slovakia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Slovakia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity measured by Numeric Rating Scale (NRS) (time frame: Baseline and 12 months follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in